Loehr A, Patnaik A, Campbell D, Shapiro J, et al. Response to rucaparib in BRCA-mutant metastatic castration-resistant prostate cancer identified by genomic testing in the TRITON2 study. Clin Cancer Res 2021 Oct 1. pii: 1078-0432.CCR-21-2199.
PMID: 34598946